Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant versus temazepam versus placebo for REM sleep and fear extinction in healthy adults
ACTRN12619001694101Phase 4Terminated
- Sponsor
- University of Melbourne
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing Suvorexant, Temazepam active control and Placebo control (3 arms). Primary endpoints: Amount of REM sleep on test night, Home sleep recording on recovery night and 1 more. Started Jan 2020; status: terminated.
02
Drugs
suvorexanttemazepam
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on ACTRN12619001694101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001694101.